Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Nov 15
Love0

Light and Laser-Imaging Detection and Ranging (LiDAR) in Dermatology: A New Dimension for Digital Healthcare

By Chuck Lin No Comments
INTRODUCTIONDermatology has benefited from multiple technological advancements, including total body photography (TBP)1,2 and teledermatology.3 These technological leaps were made possible with the introduction of digital photography, especially with the advent…
Read More
Nov 14
Love0

Social Media and the Dermatologist

By Chuck Lin No Comments
INTRODUCTIONFrom 2005 to 2020, the percentage of American adults using social media skyrocketed.1 For many, social media is a means of "researching" everyday needs, including healthcare.1,2 While mass dissemination of…
Read More
Nov 14
Love0

An Update on the Off-Label Uses of Low-Dose Naltrexone in Dermatology

By Chuck Lin No Comments
INTRODUCTIONNaltrexone is an FDA-approved opioid receptor antagonist for the treatment of opioid and alcohol use disorder at standard doses of 50 to 100 milligrams (mg) daily. Low-dose naltrexone (LDN), 1…
Read More
Nov 13
Love0

Evaluating Anti-Inflammatory Potential of Platelet-Rich Plasma in Scarring Alopecia: A Systematic Review

By Chuck Lin No Comments
INTRODUCTIONScarring alopecia, also known as cicatricial alopecia, is a hair loss due to the destruction of epithelial stem cells at the hair follicle bulge mediated by inflammation, infection, or other…
Read More
Nov 11
Love0

Mohs Micrographic Surgery for the Treatment of Lentigo Maligna and Lentigo Maligna Melanoma: An Outcomes Study

By Chuck Lin No Comments
INTRODUCTIONDue to the high risk of recurrence, excision with clear histological margins is the preferred treatment modality for lentigo maligna (LM) and lentigo maligna melanoma (LMM).1 Conventional wide-local excision (WLE)…
Read More
Oct 30
Love0

The Efficacy of Intense Pulsed Light and Laser Hair Removal in Hidradenitis Suppurativa Treatment

By Chuck Lin No Comments
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic condition that presents with inflammatory lesions which commonly present at sites bearing apocrine glands. HS is a multifactorial disease, and factors such as genetics,…
Read More
Oct 29
Love0

Attitudes on, Practices, and Recommendations for Visible Light Protection Amongst Dermatology Practitioners

By Chuck Lin No Comments
INTRODUCTIONExposure to solar radiation (SR) is associated with a range of adverse effects on the skin, including photocarcinogenesis, sunburn, photoaging, and pigmentation. While the primary focus of SR-induced pathologies has…
Read More
Oct 29
Love0

Treatment of Mild to Severe Acne Vulgaris With a 650-Microsecond 1064-nm Nd:YAG Laser

By Chuck Lin No Comments
INTRODUCTIONAcne affects approximately 50 million people in the United States.1 Therapies include retinoids, antibiotics, hormones, lights, lasers, and various combinations of these modalities.2 Topical and/or oral medications are associated with…
Read More
Oct 29
Love0

New Formulations of Acyclothymidine Dinucleosides Reduce Damaging Effects of Ultraviolet Radiation in an Ex Vivo Skin Model

By Chuck Lin No Comments
INTRODUCTIONDespite numerous public warnings about protecting the skin against sun's UV exposure and extensive research into topical protective formulations, the incidence of melanoma and non-melanoma skin cancers continues to rise.1…
Read More
Oct 29
Love0

GLP-1 Receptor Agonists for the Dermatologist: Uses and Considerations

By Chuck Lin No Comments
INTRODUCTIONThe glucagon-like peptide-1 receptor agonists (GLP1RAs) are a widely popularized drug class due to their notable success in promoting weight loss. The GLP1RAs, dulaglutide, exenatide, semaglutide, liraglutide, tirzepatide, and lixisenatide…
Read More
Oct 29
Love0

INDIVIDUAL ARTICLE: Real-World Clinical Experience With a Neuro-Peptide Serum in Combination With Botulinum Toxin Type-A Injections

By Chuck Lin No Comments
INTRODUCTIONBy 2050, the World Health Organization (WHO) estimates that the world's population of people aged 65 years and older will have more than doubled from 761 million in 2021.1 As…
Read More
Oct 29
Love0

FULL SUPPLEMENT: Real-World Clinical Experience Combining A Neuro-Peptide Serum And Botulinum Toxin Type-A Injections

By Chuck Lin No Comments
In this supplement:Real-World Clinical Experience With a Neuro-Peptide Serum in Combination With Botulinum Toxin Type-A InjectionsWe evaluated real-life experiences of a topical neuro-peptide serum containing 2% acetyl hexapeptide-8, 2% dipeptide…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • CeraVe Innovation: Haircare Reinvented with Dermatologists July 30, 2025
  • JDD Case Reports: Unlocked and Ready to Explore July 30, 2025
  • New Solutions for Moderate to Severe Dandruff from VICHY DERCOS, the #1 dermatologist-recommended anti-dandruff brand in Europe July 29, 2025
  • The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart Review July 29, 2025
  • New Solutions for Moderate to Severe Dandruff from VICHY DERCOS July 28, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search